(Q36024617)

11 August 2017

1 reference

title

Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor (English)

1 reference

11 August 2017

Christopher Cianci

1

1 reference

11 August 2017

Nicholas Meanwell

series ordinal

2

1 reference

11 August 2017

Mark Krystal

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

28 January 2005

1 reference

Journal of Antimicrobial Chemotherapy

11 August 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 August 2017

volume

55

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

289-292

1 reference

Importance of respiratory viruses in acute otitis media

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Fundamental structure-activity relationships associated with a new structural class of respiratory syncytial virus inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Orally active fusion inhibitor of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Structural characterization of the human respiratory syncytial virus fusion protein core

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

RFI-641, a potent respiratory syncytial virus inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Therapeutic options for the management of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKH558

21 January 2018

Identifiers

DOI

10.1093/JAC/DKH558

1 reference

11 August 2017

1 reference